Hologic Inc (HOLX) |
73.58 -1.57 (-2.09%)
|
02-25 11:09 |
Open: |
74.47 |
Pre. Close: |
75.15 |
High:
|
75.14 |
Low:
|
73.07 |
Volume:
|
390,758 |
Market Cap:
|
18,959M |
|
|
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, surgical products, and light-based aesthetic and medical treatment systems for women in the United States and internationally. The company offers Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for acute respiratory ailments. It also provides breast imaging and analytics, such as 2D and 3D mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company offers aesthetic treatment systems, as well as TempSure, a radio frequency energy-sourced platform, which offers non-surgical and surgical aesthetic treatments and procedures. Further, it offers NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Additionally, the company offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. |
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
76.516 - 76.94 |
76.94 - 77.284 |
Low:
|
73.491 - 74.095 |
74.095 - 74.586 |
Close:
|
74.263 - 75.158 |
75.158 - 75.884 |
|
Technical analysis |
as of: 2021-02-25 10:38:43 AM |
Overall:
|
|
Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
Target: |
Six months: 93.07 One year: 99.28 |
Support: |
Support1: 71.08 Support2: 59.14 |
Resistance: |
Resistance1: 79.68 Resistance2: 85.00 |
Pivot: |
79.72  |
Moving Average: |
MA(5): 74.99 MA(20): 79.93 
MA(100): 73.51 MA(250): 61.60  |
MACD: |
MACD(12,26): -0.46 Signal(9): 0.63  |
Stochastic oscillator: |
%K(14,3): 13.40 %D(3): 13.01  |
RSI: |
RSI(14): 38.70  |
52-week: |
High: 85.00 Low: 26.49 Change(%): 57.1 |
Average Vol(K): |
3-Month: 193626 10-Days: 223141 |
|
Price, moving averages and Bollinger Bands |
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.HOLX has closed above bottom band by 9.7%. Bollinger Bands are 66.2% wider than normal. The large width of the bands suggest high volatility as compared to HOLX's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue. |
|
Headline News |
Tue, 23 Feb 2021 Hologic Inc. (HOLX) Rises 1.25% for February 23 - Equities.com
Mon, 22 Feb 2021 Hologic Inc. stock falls Monday, underperforms market - MarketWatch
Mon, 22 Feb 2021 Here's Why You Should Add Hologic (HOLX) to Your Portfolio - Nasdaq
Fri, 19 Feb 2021 Hologic Inc. stock falls Friday, underperforms market - MarketWatch
Fri, 19 Feb 2021 Hologic is down despite Barron’s bullish view - Seeking Alpha
Wed, 17 Feb 2021 Hologic Inc. stock falls Wednesday, underperforms market - MarketWatch
|
Financial Analysis |
Growth |
 |
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
Profitability |
 |
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
Solvency |
 |
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
Efficiency |
 |
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
Return on Equity: |
Outperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: NASDAQ |
Sector: Healthcare |
Industry: Medical Instruments & Supplies |
Shares Out. (M) |
258 |
Shares Float (M) |
256 |
% Held by Insiders
|
0.57 |
% Held by Institutions
|
96.99 |
Shares Short (K)
|
3,650 |
Shares Short P. Month (K)
|
4,750 |
Stock Financials |
EPS
|
5.260 |
EPS Est This Year
|
2.010 |
EPS Est Next Year
|
2.150 |
Book Value (p.s.)
|
12.690 |
Profit Margin
|
30.50 |
Operating Margin
|
41.74 |
Return on Assets (ttm)
|
17.1 |
Return on Equity (ttm)
|
49.9 |
Qtrly Rev. Growth
|
89.3 |
Gross Profit (p.s.)
|
9.742 |
Sales Per Share
|
17.620 |
EBITDA (p.s.)
|
8.810 |
Qtrly Earnings Growth
|
69.50 |
Operating Cash Flow (M)
|
1,430 |
Levered Free Cash Flow (M)
|
1,190 |
Stock Valuations |
PE Ratio
|
14.07 |
PEG Ratio
|
|
Price to Book value
|
5.83 |
Price to Sales
|
4.20 |
Price to Cash Flow
|
13.34 |
Stock Dividends |
Dividend
|
|
Forward Dividend
|
|
Dividend Yield
|
|
Dividend Pay Date
|
Invalid DateTime. |
Ex-Dividend Date
|
Invalid DateTime. |
7 Binary Options
|
Your Ad Here
|
|